Semaglutide is not a diuretic. It belongs to a drug class called GLP-1 receptor agonists, and the FDA has approved it under three brand names (Ozempic, Wegovy, and Rybelsus) for type 2 diabetes and weight management. However, semaglutide does have a mild effect on how your kidneys handle sodium and water, which is likely why this question comes up.
How Semaglutide Affects Your Kidneys
Although semaglutide isn’t classified as a diuretic, it does promote a small amount of sodium excretion through the kidneys. It does this by blocking a sodium transporter in the kidney’s filtration system, which causes your body to flush out slightly more sodium than usual. When sodium leaves, water tends to follow, resulting in a mild reduction in fluid volume.
Semaglutide may also dampen the hormonal system that regulates blood pressure and fluid balance (sometimes called the RAAS system) and possibly boost a natural heart-produced hormone that encourages sodium excretion. These are subtle effects, not the dramatic fluid shifts you’d see with an actual diuretic like furosemide or hydrochlorothiazide. The distinction matters: diuretics are specifically designed to force fluid loss, while semaglutide’s primary job is elsewhere entirely.
Why It Lowers Blood Pressure Without Being a Diuretic
Semaglutide does lower blood pressure, which can make it seem like it’s working as a diuretic. A large meta-analysis published in the European Heart Journal found that people taking semaglutide saw their systolic blood pressure drop by about 5 mmHg more than those on placebo. But the same analysis showed that roughly 89% of that blood pressure reduction was explained by weight loss alone. Once researchers accounted for changes in body weight, the blood pressure effect essentially disappeared.
So while the mild sodium-flushing action of semaglutide could contribute a small amount, the real driver of lower blood pressure is losing weight. Fat tissue produces hormones and inflammatory signals that raise blood pressure, and as that tissue shrinks, pressure comes down.
Semaglutide vs. Drugs With True Diuretic Effects
If you’re looking for a useful comparison, SGLT2 inhibitors (like empagliflozin and dapagliflozin) are another class of diabetes drugs that have a much more pronounced diuretic-like effect. They work by blocking glucose reabsorption in the kidneys, which pulls both sugar and sodium into the urine and increases urine volume noticeably. Clinical guidelines actually note that SGLT2 inhibitors are preferred over GLP-1 drugs like semaglutide in situations where patients have significant cardiovascular risk or heavy protein in their urine, partly because of this fluid-lowering action. Semaglutide, by contrast, is favored when weight loss or blood sugar control is the priority “without volume depletion.”
That phrasing is telling. Researchers specifically describe semaglutide as a drug that doesn’t cause meaningful volume depletion, which is the opposite of what a diuretic does.
Dehydration Risk Is Real, but Not From a Diuretic Effect
People on semaglutide do sometimes get dehydrated, but the reason usually isn’t kidney-related. The more common culprits are the gastrointestinal side effects: nausea, vomiting, and diarrhea, all of which can cause significant fluid loss, especially in the first weeks after starting or increasing a dose. Reduced appetite can also mean you’re eating fewer water-rich foods and drinking less throughout the day without realizing it.
General hydration guidelines suggest about 11.5 cups of fluid daily for women and 15.5 cups for men, though individual needs vary with activity level, climate, and body size. Fresh fruits and vegetables count toward that total. If you’re experiencing frequent vomiting or diarrhea on semaglutide, your fluid needs will be higher than average.
Kidney Protection Over Time
Rather than stressing the kidneys the way aggressive diuretics can, semaglutide appears to protect them. The 2024 FLOW trial, a large study of people with type 2 diabetes and chronic kidney disease, found that semaglutide reduced the risk of major kidney events by 24% compared to placebo. People on semaglutide also lost kidney function more slowly, with their filtration rate declining by about 1.16 ml per minute per year less than those on placebo. These results suggest semaglutide helps preserve kidney function rather than taxing it through fluid removal.
The kidney benefits likely come from reduced inflammation, lower blood sugar, weight loss, and the mild reduction in pressure within the kidney’s filtering units, not from any diuretic-like flushing of fluid.